
Home » NEUROMETRIX, INC. REPORTS TOTAL REVENUES OF $10.3 MILLION FOR THE FOURTH QUARTER 2005, 79% GROWTH OVER FOURTH QUARTER 2004
NEUROMETRIX, INC. REPORTS TOTAL REVENUES OF $10.3 MILLION FOR THE FOURTH QUARTER 2005, 79% GROWTH OVER FOURTH QUARTER 2004
NeuroMetrix, Inc., a medical device company focused on the design, development
and sale of proprietary products used to diagnose neuropathies, or diseases
of the nerves, announced today the financial results for the three month and
twelve month periods ended December 31, 2005. Total revenues for the three months
ended December 31, 2005, the Company's fourth quarter, were $10.3 million, compared
with $5.8 million for the fourth quarter of 2004, representing an increase of
79%.
Genetic
Engineering News
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
05Dec
-
07Dec
-
13Dec
-
14Apr